Cargando…

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Precision medicine in oncology poses unique challenges to the generation of clinical and economic evidence used for cost-effectiveness analyses that can inform health technology assessment. The conduct of randomized controlled trials for biomarker-specific therapies targeted towards small population...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Kelvin K. W., Cheung, Matthew C., Regier, Dean A., Hay, Annette, Louie, Alexander V., Cheung, Winson Y., Tarride, Jean-Eric, Udayakumar, Suji, Mittmann, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482104/ https://www.ncbi.nlm.nih.gov/pubmed/34590616 http://dx.doi.org/10.3390/curroncol28050311

Ejemplares similares

Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials
por: Cheung, Matthew C, et al.
Publicado: (2021)

Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities
por: Wilson, Brooke E, et al.
Publicado: (2023)

Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
por: Everest, Louis, et al.
Publicado: (2023)

Dental economics: Past, present, and the future
por: Pandit, Nymphea
Publicado: (2020)

The past, present, and future of health economics in India
por: Singh, Nihaal, et al.
Publicado: (2022)

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial
por: Hoch, Jeffrey S., et al.
Publicado: (2019)

Health Economics at the Crossroads of Centuries – From the Past to the Future
por: Jakovljevic, Mihajlo (Michael), et al.
Publicado: (2016)

Discrete Choice Experiments in Health Economics: Past, Present and Future
por: Soekhai, Vikas, et al.
Publicado: (2018)

The economic case for precision medicine
por: Gavan, Sean P., et al.
Publicado: (2018)

The social and economic determinants of suicide in Canadian provinces
por: Jalles, João T, et al.
Publicado: (2015)

Economics of Obesity — Learning from the Past to Contribute to a Better Future
por: Ananthapavan, Jaithri, et al.
Publicado: (2014)

A perspective on the economic valorization of gene manipulated biotechnology: Past and future()
por: Knockaert, Mirjam, et al.
Publicado: (2015)

Economic evaluation of smoking cessation in Ontario's regional cancer programs
por: Djalalov, Sandjar, et al.
Publicado: (2018)

Mathematical economics /
por: Lancaster, Kelvin
Publicado: (1987)

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
por: Hay, Annette E, et al.
Publicado: (2021)

Insights Offered by Economic Analyses
por: Herman, William H.
Publicado: (2014)

Integrating Socio-Economic Determinants of Canadian Women's Health
por: Vissandjee, Bilkis, et al.
Publicado: (2004)

Economic Burden of Not Complying with Canadian Food Recommendations in 2018
por: Loewen, Olivia K., et al.
Publicado: (2019)

Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses
por: Henderson, Raymond, et al.
Publicado: (2019)

Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
por: Ball, Graeme, et al.
Publicado: (2017)

Ethics Committees in India: Past, present and future
por: Thatte, Urmila M., et al.
Publicado: (2017)

Subject expert committees: Past, present, and future
por: Bhave, Amita, et al.
Publicado: (2019)

Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology
por: Ball, Graeme, et al.
Publicado: (2021)

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
por: Cressman, Sonya, et al.
Publicado: (2016)

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES
por: Ofman, Joshua J., et al.
Publicado: (2003)

Estimating the Cost of Cancer Care in British Columbia and Ontario: A Canadian Inter-Provincial Comparison
por: De Oliveira, Claire, et al.
Publicado: (2017)

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
por: Prica, Anca, et al.
Publicado: (2021)

Economic Impact of Hospitalization Past Maximal Neurosurgical Inpatient Benefit
por: Rogers, Cara M, et al.
Publicado: (2018)

A Comparison of Patients’ and Physicians’ Knowledge and Expectations Regarding Precision Oncology Tests
por: Dehar, Navdeep, et al.
Publicado: (2022)

FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment
por: Ho, Cheryl, et al.
Publicado: (2022)

Managerial economics /
por: Dean, Joel, 1906-1979
Publicado: (1951)

The Economic and Long-Term Health Consequences of Canadian COVID-19 Lockdowns
por: Bryan, Kevin A., et al.
Publicado: (2021)

Past, Present, and Future of Veterinary Epidemiology and Economics: One Health, Many Challenges, No Silver Bullets
por: Perez, Andres M.
Publicado: (2015)

How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future
por: Standaert, Baudouin, et al.
Publicado: (2020)

Economic development : past and present /
por: Gill, Richard T. (Richard Thomas), 1927-2010
Publicado: (1967)

Transparency Needed for Economic Analyses of PA Programs
por: Holdford, David
Publicado: (2003)

Past world economic production constrains current energy demands: Persistent scaling with implications for economic growth and climate change mitigation
por: Garrett, Timothy J., et al.
Publicado: (2020)

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort
por: Gibson, Amanda J. W., et al.
Publicado: (2022)

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
por: Tarride, Jean-Eric, et al.
Publicado: (2018)

Precision Medicine in Cholangiocarcinoma: Past, Present, and Future
por: Cheng, Chi-Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gg853bfhpqlueqife3metbthj9